Alzheimer Europe has a new-look newsletter for 2024!
OurJanuary 2024 editionbrings you the latest news on developments in the dementia field, across Europe and beyond.
Summaries of a few of our top stories appear below.
Our monthly newsletter reaches thousands of people with an interest in the field, from across Europe and beyond. We are always happy to receive feedback, or suggestions regarding news items to share.
In a new position paper, and following engagement with its national members and the European Working Group of People with Dementia (EWGPWD), Alzheimer Europe calls for concrete actions to enable timely, safe and equitable access to anti-amyloid drugs, for patients who are most likely to benefit from these innovative new treatments for Alzheimer’s disease (AD).
In advance of the European Parliament elections between 6 and 9 June 2024, Alzheimer Europe has launched its European Election Campaign 2024, aiming to make dementia a priority issue for decision-makers at a European level.
We are proud to present a set of interviews filmed during our recent series of consultations on Public Involvement in dementia and brain health research. The interviews are with members of the Advisory Boards of the six EU projects attending this international event, as well as project researchers and the FNR - Luxembourg National Research Fund programme manager.
We are delighted to be a partner in a brand new Innovative Health Initiative (IHI)-funded interdisciplinary project aiming to transform Alzheimer’s disease diagnosis, prevention and treatment. The project is called AD-RIDDLE.
On 31 January 2024, Alzheimer Europe launched its 2023 Dementia in Europe Yearbook dedicated to legal capacity and supported decision-making for people living with a diagnosis of dementia.
Alzheimer Europe has a new-look newsletter for 2024!
In a new position paper, and following engagement with its national members and the European Working Group of People with Dementia (EWGPWD), Alzheimer Europe calls for concrete actions to enable timely, safe and equitable access to anti-amyloid drugs, for patients who are most likely to benefit from these innovative new treatments for Alzheimer’s disease (AD).
In advance of the European Parliament elections between 6 and 9 June 2024, Alzheimer Europe has launched its European Election Campaign 2024, aiming to make dementia a priority issue for decision-makers at a European level.
We are proud to present a set of interviews filmed during our recent series of consultations on Public Involvement in dementia and brain health research. The interviews are with members of the Advisory Boards of the six EU projects attending this international event, as well as project researchers and the FNR - Luxembourg National Research Fund programme manager.
We are delighted to be a partner in a brand new Innovative Health Initiative (IHI)-funded interdisciplinary project aiming to transform Alzheimer’s disease diagnosis, prevention and treatment. The project is called AD-RIDDLE.
On 31 January 2024, Alzheimer Europe launched its 2023 Dementia in Europe Yearbook dedicated to legal capacity and supported decision-making for people living with a diagnosis of dementia. 